Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

Two cases involving patients diagnosed with localized prostate cancer and treated with MRI-
guided focal therapies are presented. Patient selection procedures, techniques, outcomes …

Background Long-term patient-reported outcomes are needed to inform treatment decisions
for localized prostate cancer. Methods Patient-reported outcomes of 1643 randomly …

Simple Summary Prostate cancer is the most common malignancy (after skin cancer) in
men, and also the most common cancer among cancer survivors in the US. We assessed …

Importance Recent data suggest that local treatment with radical prostatectomy or radiation
may improve survival outcomes in men with advanced prostate cancer. However, evidence …

Multiparametric MRI (mpMRI) of the prostate aids risk stratification of patients with elevated
PSA levels. Although most clinically significant prostate cancers are detected by mpMRI …

Context Treatment choice for localised prostate cancer remains a significant challenge for
patients and clinicians, with uncertainty over decisions potentially leading to conflict and …

Background Multiparametric magnetic resonance imaging (mpMRI)/transrectal ultrasound
(TRUS) fusion-guided high-intensity focused ultrasound (HIFU) is a focal treatment option for …

Background Surgery and radiotherapy are primary nonconservative treatments for prostate
cancer (PCa). However, personalizing treatment options between these treatment modalities …

Simple Summary This multicenter study investigated the extent of patient's decision regret
(PatR) in patients with prostate cancer comparing different surgical modalities. Robot …